{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:23:18Z","timestamp":1774527798743,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Instituto Brasileiro do F\u00edgado"},{"name":"Sociedade Brasileira de Hepatologia"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07654-x","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T02:02:36Z","timestamp":1661133756000},"page":"514-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-2152","authenticated-orcid":false,"given":"Guilherme Grossi Lopes","family":"Can\u00e7ado","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia Alves","family":"Couto","sequence":"additional","affiliation":[]},{"given":"Debora Raquel Benedita","family":"Terrabuio","sequence":"additional","affiliation":[]},{"given":"Eduardo Luiz Rachid","family":"Can\u00e7ado","sequence":"additional","affiliation":[]},{"given":"Cristiane Alves","family":"Villela-Nogueira","sequence":"additional","affiliation":[]},{"given":"Maria Lucia Gomes","family":"Ferraz","sequence":"additional","affiliation":[]},{"given":"Michelle Harriz","family":"Braga","sequence":"additional","affiliation":[]},{"given":"Mateus Jorge","family":"Nardelli","sequence":"additional","affiliation":[]},{"given":"Luciana Costa","family":"Faria","sequence":"additional","affiliation":[]},{"given":"Nathalia Mota","family":"de Faria Gomes","sequence":"additional","affiliation":[]},{"given":"Elze Maria Gomes","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Vivian","family":"Rotman","sequence":"additional","affiliation":[]},{"given":"Maria Beatriz","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Simone Muniz Carvalho Fernandes","family":"da Cunha","sequence":"additional","affiliation":[]},{"given":"Marlone","family":"Cunha-Silva","sequence":"additional","affiliation":[]},{"given":"Liliana Sampaio Costa","family":"Mendes","sequence":"additional","affiliation":[]},{"given":"Claudia Alexandra Pontes","family":"Ivantes","sequence":"additional","affiliation":[]},{"given":"Liana","family":"Codes","sequence":"additional","affiliation":[]},{"given":"Val\u00e9ria Ferreira","family":"de Almeida e Borges","sequence":"additional","affiliation":[]},{"given":"Fabio Heleno","family":"de Lima Pace","sequence":"additional","affiliation":[]},{"given":"Mario Guimar\u00e3es","family":"Pessoa","sequence":"additional","affiliation":[]},{"given":"Laura Vilar","family":"Guedes","sequence":"additional","affiliation":[]},{"given":"Izabelle Venturini","family":"Signorelli","sequence":"additional","affiliation":[]},{"given":"Gabriela Perdomo","family":"Coral","sequence":"additional","affiliation":[]},{"given":"Cynthia","family":"Levy","sequence":"additional","affiliation":[]},{"given":"Paulo Lisboa","family":"Bittencourt","sequence":"additional","affiliation":[]},{"name":"Members of the Brazilian Cholestasis Study Group Consortium","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"7654_CR1","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1053\/jhep.2000.20240","volume":"32","author":"C Corpechot","year":"2000","unstructured":"Corpechot C, Carrat F, Bonnand AM et al. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology. 2000;32:1196\u20131199.","journal-title":"Hepatology."},{"key":"7654_CR2","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871\u2013877.","journal-title":"Hepatology."},{"key":"7654_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2019;71:357\u2013365.","journal-title":"J Hepatol."},{"key":"7654_CR4","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"147","author":"WJ Lammers","year":"2014","unstructured":"Lammers WJ, van Buuren HR, Hirschfield GM et al. Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology. 2014;147:1338-1349.e5.","journal-title":"Gastroenterology."},{"key":"7654_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.hepres.2004.04.001","volume":"29","author":"J Itakura","year":"2004","unstructured":"Itakura J, Izumi N, Nishimura Y et al. Prospective randomized crossover trial of combination therapy with bezafibrate and UDCA for primary biliary cirrhosis. Hepatol Res. 2004;29:216\u2013222.","journal-title":"Hepatol Res."},{"key":"7654_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/liv.12290","volume":"34","author":"S Lens","year":"2014","unstructured":"Lens S, Leoz M, Nazal L et al. Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid. Liver Int. 2014;34:197\u2013203.","journal-title":"Liver Int."},{"key":"7654_CR7","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","volume":"378","author":"C Corpechot","year":"2018","unstructured":"Corpechot C, Chazouill\u00e8res O, Rousseau A et al. A placebo-controlled trial of bezafibrate in primary biliary cholangitis. N Engl J Med. 2018;378:2171\u20132181.","journal-title":"N Engl J Med."},{"key":"7654_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens F, Andreone P, Mazzella G et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med. 2016;375:631\u2013643.","journal-title":"N Engl J Med."},{"key":"7654_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S2468-1253(19)30094-9","volume":"4","author":"M Trauner","year":"2019","unstructured":"Trauner M, Nevens F, Shiffman ML et al. Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study. Lancet Gastroenterol Hepatol. 2019;4:445\u2013453.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"3","key":"7654_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2021.04.010","volume":"75","author":"A Tanaka","year":"2021","unstructured":"Tanaka A, Hirohara J, Nakano T et al. Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis. J Hepatol. 2021;75:565\u2013571.","journal-title":"J Hepatol."},{"key":"7654_CR11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","volume":"69","author":"KD Lindor","year":"2019","unstructured":"Lindor KD, Bowlus CL, Boyer J et al. Primary biliary cholangitis: 2018 Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2019;69:394\u2013419.","journal-title":"Hepatology."},{"key":"7654_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00432479","volume":"379","author":"J Ludwig","year":"1978","unstructured":"Ludwig J, Dickson ER, McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 1978;379:103\u2013112.","journal-title":"Virchows Arch A Pathol Anat Histol."},{"key":"7654_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Par\u00e9s","year":"2006","unstructured":"Par\u00e9s A, Caballer\u00eda L, Rod\u00e9s J. Excellent long-term Survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715\u2013720.","journal-title":"Gastroenterology."},{"key":"7654_CR14","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","volume":"55","author":"C Corpechot","year":"2011","unstructured":"Corpechot C, Chazouill\u00e8res O, Poupon R. Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361\u20131367.","journal-title":"J Hepatol."},{"key":"7654_CR15","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE et al. Baseline Ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:2186\u20132194.","journal-title":"Am J Gastroenterol."},{"key":"7654_CR16","unstructured":"Haynes R. Determinants of compliance: The disease and the mechanics of treatment. Compliance in health care. 1979."},{"issue":"1","key":"7654_CR17","doi-asserted-by":"publisher","first-page":"100546","DOI":"10.1016\/j.aohep.2021.100546","volume":"27","author":"GGL Can\u00e7ado","year":"2022","unstructured":"Can\u00e7ado GGL, Braga MH, Ferraz MLG et al. Clinical features and treatment outcomes of primary biliary cholangitis in a highly admixed population. Ann Hepatol. 2022;27:100546.","journal-title":"Ann Hepatol."},{"key":"7654_CR18","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","volume":"386","author":"EJ Carey","year":"2015","unstructured":"Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet (London, England). 2015;386:1565\u20131575.","journal-title":"Lancet (London, England)."},{"issue":"2","key":"7654_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","volume":"128","author":"C Corpechot","year":"2005","unstructured":"Corpechot C, Carrat F, Bahr A et al. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology. 2005;128:297\u2013303.","journal-title":"Gastroenterology."},{"issue":"10","key":"7654_CR20","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00535-013-0903-1","volume":"49","author":"C Lammert","year":"2014","unstructured":"Lammert C, Juran BD, Schlicht E et al. Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. J Gastroenterol. 2014;49:1414\u20131420.","journal-title":"J Gastroenterol."},{"issue":"2","key":"7654_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1478-3231.1999.tb00020.x","volume":"19","author":"P Angulo","year":"1999","unstructured":"Angulo P, Lindor KD, Therneau TM et al. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver. 1999;19:115\u2013121.","journal-title":"Liver."},{"key":"7654_CR22","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.14309\/ajg.0000000000000557","volume":"115","author":"CFM Perez","year":"2020","unstructured":"Perez CFM, Harms MH, Lindor KD et al. Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase. Am J Gastroenterol. 2020;115:1066\u20131074.","journal-title":"Am J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07654-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07654-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07654-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T00:13:22Z","timestamp":1700957602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07654-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7654"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07654-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}